Relign Corporation

RELIGN is a startup company in the heart of Silicon Valley dedicated to innovation in arthroscopy and resection, focused on providing surgeons with best-in-class products that provide unequaled efficiency and control. We are trailblazers in the field of arthroscopy and are committed to the radical evolution of resection technology. Leveraging our years of experience, progressive research and development, and surgeon feedback, RELIGN launched the Tricera™ System. Tricera is a revolutionary, advanced system that combines ablation/coagulation, tissue resection, bone cutting, and fluid management into one unique system. The software in the Tricera System simultaneously controls these combined functions to provide surgeons with ultimate control of the arthroscopic environment. Veriflow™ inflow/outflow fluid management is incorporated directly into the Tricera Controller and automatically manages fluid pressure with unparalleled accuracy. With advanced All-in-One technology, RELIGN has created a versatile platform of surgical devices including devices that feature a smaller reciprocating electrode for aggressive tissue ablation and resection, as well as devices that offer combined aggressive bone burring, resection and ablation in a single device. These combination features provide exceptional device performance and control while allowing surgeons to switch modes without exchanging devices intraoperatively. RELIGN continues to put a strong emphasis on research and development to work towards providing quality, effective solutions for surgeons to further advance arthroscopic surgery.